Clinical efficiency of medium and high doses of valsartan in the treatment of patient with arterial hypertension and chronic kidney diseases

Cover Page

Abstract


The results of the study, which shows the efficiency of antihypertensive and nephroprotektive angiotensin II receptor blocker valsartan in patients with arterial hypertension of and chronic kidney disease. Dose dependence was confirmed nephroprotective and antihypertensive effects of valsartan, and also marked by a high safety profile of the drug in the average and maximum therapeutic doses.

About the authors

M L Maximov

I.M. Sechenov MMA

Кафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA

O V Dralova

I.M. Sechenov MMA

Кафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA

References

Statistics

Views

Abstract - 186

PDF (Russian) - 44

Cited-By



Copyright (c) 2010 Максимов М.Л., Дралова О.В.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies